Cancer Genetics:
Cancer is a genetic issue in which the typical control of cell improvement is lost. Cancer genetics is presently one of the quickest stretching out restorative distinguishing strengths. At the nuclear dimension, the tumor is brought about by a mutation(s) in DNA, which result in twisted cell development. An expansive part of these changes is secured and occur in physical cells. In any case, a couple of individuals secure mutation(s) in the germ line. The mutation(s) occur in two classes of cell characteristics: oncogenes and tumor silencer characteristics. Under standard conditions, tumor silencer characteristics oversee cell division and camouflage of extension. Changes in these characteristics result in unchecked cell duplication realizing tumors with strange cell cycles and tumor development. The tumor silencer characteristics add to malady by the inactivating of loss of limit change.
Related Conference of Cancer Genetics:
18th International Conference on Human Genomics and Genomic Medicine
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Cancer Genetics: Conference Speakers
Recommended Sessions
- Genetic Disorders
- Biochemical Genetics:
- Cancer Genetics:
- Clinical Genetics:
- Cytogenetics:
- Developmental Genetics:
- Epigenetics
- Ethical & Social Implications of Gene Editing:
- Gene Therapy
- Gene Therapy and Genetic Counseling:
- Genetic Counseling:
- Genomic Medicine & Molecular Diagnostics:
- Genomics:
- Human Genetic Engineering:
- Human genetics
- Immunogenetics:
- Medical Genetics
- Nutritional Genomics:
- Oncogenomics and Cancer Heredity:
- Pharmacogenetics:
- Stem Cell Research and Therapy:
- Stem Cell Research:
- Stem cell Therapy:
- Molecular Genetics
- Population Genetics:
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)
